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Background: Apoptosis can occur in red blood cells (RBC) and seems to be involved in hematologic disorders
related to many diseases. In malaria it is known that parasitized RBC (pRBC) is involved in the development of
anemia and thrombosis; however, non-parasitized RBC (nRBC) apoptosis could amplify these malaria-associated
hematologic events. In fact, in experimental malaria, increased levels of apoptosis were observed in nRBC during
lethal Plasmodium yoelii 17XL infection, but in human malaria erythrocytic apoptosis has never been studied. The
present study was performed to investigate if nRBC apoptosis also occurs in P. vivax and P. falciparum infections.
Findings: Apoptosis of nRBC was evaluated in blood samples of P. vivax malaria patients and clinically healthly
individuals living in Manaus, Brazil, both ex vivo and after incubation of RBC for 24 h. Additionally, the capacity of
plasma from P. vivax or P. falciparum patients was tested for induction of in vitro apoptosis of normal RBC from a
clinically healthy individual living in a non-endemic malaria region. Apoptosis was detected by flow cytometry using
annexin V staining. In contrast to experimental malaria that significantly increased the levels of apoptotic nRBC both
ex-vivo and after 24 h of incubation, no significant alteration on apoptotic nRBC rates was detected in P. vivax
infected patients when compared with non-infected control individuals. Similar results were observed when plasma
of these P. vivax patients was incubated with normal RBC. Conversely, plasma from P. falciparum-infected subjects
induced significant apoptosis of these cells.
Conclusions: Apoptosis of normal RBC can be induced by plasma from individuals with P. falciparum (but not with
P. vivax) malaria. This finding could reflect the existence of erythrocytic apoptosis during infection that could
contribute to the pathogenesis of hematological and vascular complications associated with falciparum malaria.Findings
It is currently known that the physiological processes of
apoptotic cell death are not restricted to nucleated cells,
occurring also in cells lacking a nucleus and organelles,
such as the red blood cells (RBC) [1]. Similar to apop-
tosis of nucleated cells, erythrocytic apoptosis is trig-
gered by different endogenous and exogenous stimuli
and is characterized by many cellular changes leading to
cell elimination [1,2]. These changes include exposure
of phosphatidylserine (PS) on the cell surface, which
drives dying cells to degradation by phagocytosis [3]
or, alternatively, mediates cell adhesion on endothelium* Correspondence: prtotino@ioc.fiocruz.br
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unless otherwise stated.[4]. It is believed, therefore, that erythrocytic apoptosis
could participate in the pathogenesis of clinical disor-
ders in which enhanced levels of apoptotic RBC are a
common feature, such as iron and glucose-6-phosphate
dehydrogenase-(G6PD) deficiency, diabetes, renal insuf-
ficiency, hemolytic uremic syndrome, sickle-cell disease,
sepsis and mycoplasma infection [2].
In malaria, pRBC apoptosis was detected in experi-
mental P. yoelii 17XL [5] and P. berghei ANKA [6] ro-
dent malaria as well as in vitro P. falciparum culture [7],
and this process could contribute to parasite clearance.
However, an increase in the levels of apoptotic non-
parasitized RBC (nRBC) was further evidenced in P. yoelii
infection, pointing to the putative role of erythrocytic
apoptosis in the pathogenesis of malaria [8]. Since apop-
totic nRBC has not yet been assessed in human malariaLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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issue in Brazilian malarious patients.
For this, the levels of nRBC apoptosis were examined
in peripheral blood of 20 malarious patients infected by
P. vivax – the species that accounts annually for around
82% of malaria cases in Brazil [9,10]. Patients present-
ing positive by thick blood smear were recruited at
the Tropical Medicine Foundation Dr. Heitor Vieira
Dourado (Manaus, Amazonas, Brazil) and, then, venous
blood samples were collected in EDTA tubes. Plasma and
RBC were separated by centrifugation at 350 g for 10 min;
plasma was stored in liquid nitrogen and RBC were used
for apoptosis assays. Blood samples from 10 clinically
healthy individuals living in the same area and presenting
as negative by thick blood smear and no history of previ-
ous malaria episodes were used as controls. During the
blood collection no cases of P. falciparum malaria or com-
plicated P. vivax malaria attended the Tropical Medicine
Foundation. The study was approved by the Tropical
Medicine Foundation Ethical Committee.
Parasitemia was estimated by examination of thick
blood smears using a semi-quantitative method, as de-
scribed previously [11]. As shown in Table 1, the majorly
of P. vivax patients (n = 11) presented parasitemia ran-
ging from 501 to 10,000 parasites/μL. In two patients
parasitemia was between 301 and 500 parasites/μL and
in seven it was less than 300.
Apoptosis was assayed both ex vivo and after RBC in-
cubation for 24 h at 37°C at a hematocrit of 0.5% in Ringer
solution containing (in mM) 125 NaCl, 5 KCl, 1 MgSO4,
32 N-2-hydroxyethylpiperazine-N-2-ethanesulfonic acid
(HEPES), 5 glucose, and 1 CaCl2 (pH 7.4). Apoptotic
nRBC was detected through flow cytometry using Syto 16
and annexin V-PE double staining, as performed in our
previous studies with P. yoelii 17XL [5,8]. However, in
contrast to experimental malaria, that significantly in-
creased the levels of apoptotic nRBC both ex-vivo and
after 24 h incubation, no significant alteration of nRBC
apoptosis rates was detected in P. vivax patients (mean ±
SD: ex vivo, 0.73 ± 0.31%; 24 h, 1.13 ± 0.57%) when com-
pared with non-infected control individuals (ex vivo,
0.78 ± 0.27%; 24 h, 1.03 ± 0.41%) (p > 0.05; non-parametricTable 1 Semi-quantitative parasitemia in P. vivax and
P. falciparum patients, according to Lança et al., 2012 [11]
Semi-quantitative parasitemia (parasites/μL)
<+ + ++ +++
(≤300) (301–500) (501–10,000) (10,001-100,000)
P. vivax (n = 20) 07 02 11 —
P. falciparum
(n = 10)
— — 08 02
n = number
of patientsMann Whitney test). The same was true when P. vivax
patients were grouped according to parasitemia density
(data not shown).
This lack of erythrocytic apoptosis seems to be in con-
sonance with the pathogenic profile of P. vivax. Although
some reports have considered that P. vivax can induce se-
vere manifestations, including acute anemia [12-14], it is
classically known that infection by this parasite frequently
course as a benign disease. Indeed, in contrast to P. falcip-
arum, it has been believed that a simple infection by P.
vivax is per se slightly competent to induce complications
and that severe cases of vivax malaria are attributed to co-
morbidities as well as high rates of P. vivax recurrence in
areas of intense transmission as a result of drug resistance,
relapse from hypnozoites or reinfection with heterologous
strains [15,16]. In Brazil, where P. vivax is the predomin-
ant human malaria parasite and the intensity of transmis-
sion is low, severe malaria is rarely registered [9,10].
Since the classically known lower pathogenic potential
of P. vivax [17] could be insufficient to stimulate erythro-
cytic apoptosis, we explored the proapoptotic effect of
plasma from 10 patients with uncomplicated P. falcip-
arum malaria also from Manaus, whose parasitemias are
shown in Table 1, as well as from the 20 patients with P.
vivax malaria previously studied here. A pool of plasma
was tested in parallel, it was obtained from BALB/c mice
either at early (4 day) or at late (7 day) stages of lethal P.
yoelii 17XL infection [8], when mean parasitemias were,
respectively, 25% and 76%, as estimated by counting the
number of pRBC in thin blood smears. Plasmas from clin-
ically healthy individuals living in Manaus and a pool of
plasmas from non-infected BALB/c mice were also used
as controls. Induction of apoptosis was evaluated using
normal RBC (O+) from a clinically healthy individual liv-
ing in a non-endemic malaria area. Normal RBC were
incubated for 24 h and 48 h at 37°C in 5% CO2 in a 5%
hematocrit with the plasma samples. Erythrocytic apop-
tosis was detected by flow cytometry using annexin V sin-
gle staining, as previously described [18].
Consistent with the data herein observed with nRBC
from the P. vivax malarious patients, plasma from these
subjects did not show any proapoptotic effects on RBC
from the clinically healthy individual (Figures 1 and 2),
independently of parasitemia density (data not shown).
In contrast, plasma from P. falciparum infected patients
stimulated a significant increase in the levels of apoptotic
RBC after 48h of incubation (Figures 1 and 2). One of the
P. falciparum plasmas showed an important proapoptotic
effect (around 30%; Figure 1F), although no co-morbidity
that could lead to the increased induction of RBC apop-
tosis could be diagnosed in this patient. It is remarkable
that even when this patient was not considered in analysis,
plasma from the P. falciparum patients significantly in-

















Figure 1 Representative flow cytometry analysis of erythrocytic apoptosis induced by plasma. Red blood cells (RBC) from a healthy
individual were incubated for 48 h in plasma from control mice (A), P. yoelii-infected mice (B, early and; C, late stage of infection), healthy control
individuals (D) or malaria patients infected with P. vivax (E) or P. falciparum (F). Apoptosis of RBC was detected using annexin V staining.
Figure 2 Induction of apoptosis in normal red blood cells (RBC) by plasma from P. falciparum patients. RBC from a healthy individual
were incubated for 24h and 48h in the presence of plasma samples from non-infected control healthy individuals or from malaria patients
infected with P. vivax (Pv) or P. falciparum (Pf). Apoptosis was detected by flow cytometry using annexin V staining. Statistical difference was
tested by non-parametric Mann Whitney test.
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parametric Mann Whitney test). Similar to the plasma
from P. falciparum patients, plasma from P. yoelii 17XL-
infected BALB/c mice obtained at the stage of infection
related to increased induction of nRBC apoptosis in vivo
(late stage) [8], but not those obtained at a stage in
which apoptotic nRBC was not significantly detected
(early stage) [8], induced apoptosis in a high percentage
(96%) of human normal RBC after 48 h of incubation
(Figure 1), supporting the possibility of nRBC apoptosis
induction during P. falciparum infection. However, it was
not possible to statistically infer the relationship between
parasite load and apoptotic levels during falciparum mal-
aria, because the majority of P. falciparum patients pre-
sented similar parasitemia levels (Table 1).
If the proapoptotic properties of plasma from malari-
ous patients do reflect the aptness of malaria parasites toD
A B
Figure 3 Cell membrane integrity and cell volume in erythrocytic apo
incubated for 48 h in the presence of plasma from non-infected control hea
analysis of cell membrane integrity accessed by calcein-AM and annexin V-A
individuals (A) or from P. vivax (B) or P. falciparum (C) patients. (D) Forward s
incubation with plasma from control non-infected individuals or patients infe
was tested by non-parametric Mann Whitney test.induce apoptosis of normal RBC, the observation repor-
ted here seems to match the different pathogenic poten-
tials displayed between them. In this context, it would
not be surprising that the most deadly human malaria
parasite, P. falciparum [17], stimulates higher levels of
erythrocytic apoptosis that, in turn, could play a role in
development of severe malaria through precocious elim-
ination of RBC as well as occlusion of microvasculature,
as suggested in studies demonstrating in vitro adhesive-
ness of apoptotic RBC to endothelial cells [19,20]. Simi-
lar phenomena related to erythrocytic apoptosis could
also contribute to lethality of infection by P. yoelli 17XL
in BALB/c mice [21], in which massive adsorption of
parasite antigens on nRBC membrane due to the high
parasite load seems to be the main inducer of apoptosis
[8]. In the present study, however, the influence of human
malaria parasitemia on erythrocytic apoptosis inductionC
ptosis induced by plasma. RBC from a healthy individual were
lthy individuals or malaria patients. (A-C) Representative flow cytometry
PC double staining in RBC incubated with plasma from non-infected
catter of RBC exposing (AnV+) or not (AnV-) phosphatidylserine after
cted by P. vivax (Pv) or P. falciparum (Pf). Statistical difference in (D)
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by a semi-quantitative method. Nevertheless, it is known
that the number of pRBC present in peripheral blood
of P. falciparum patients does not usually reflect actual
parasite load due to sequestration phenomenon of mature
forms of the parasite [22]. Thus, although the majority of
patients presented parasitemia that did not exceed 10,000
parasites/μL (Table 1), it is possible that parasitemia in
falciparum patients was higher and the induction of
apoptosis could be related to parasite density. Moreover,
the strong proinflammatory imbalance maintained during
P. falciparum, but not during P. vivax infection [23], could
also contribute to erythrocytic apoptosis observed herein.
Taking into account that labeling of PS by annexin V
also occurs in non-apoptotic cells that suffered plasma
membrane damage [24,25], cell membrane integrity as
well as cell shrinkage were examined by flow cytometry,
as additional markers of the apoptotic process, to ensure
that RBC incubated with plasma were undergoing apop-
tosis. For this purpose, RBC from a clinically healthy in-
dividual were incubated for 48h with plasma samples (as
already described) and, then, cell volume change was mea-
sured by forward scatter and cell membrane permeabi-
lity was assessed using calcein-AM and annexin V-APC
double staining as previously described [26]. In this way, it
was possible to observe that PS-exposing RBC (AnV+)
maintained cell membrane integrity and showed a de-
crease in cell volume, supporting that erythrocytic death
process induced by plasma from P. falciparum patients
was related to apoptosis (Figure 3).
In conclusion, the present study showed that plasma
from patients with malaria caused by P. falciparum can
induce apoptosis of normal erythrocytes in vitro, point-
ing to the possibility that this phenomenon does exist
in vivo. This property was not recorded when plasma
from patients with malaria by a less pathogenic human
malaria parasite, P. vivax was studied. Further ex vivo
studies are required to confirm the existence of apop-
tosis of nRBC during P. falciparum malaria to better ad-
dress its clinical significance in malaria pathogenesis.
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